Superb Microvascular Imaging Is Superior to Doppler Imaging in Ruling Out Ulcerative Colitis Disease Activity

Area of Science:

• Gastroenterology
• Medical Imaging
• Ultrasound Technology

Background:

• Inflammatory bowel disease (IBD) requires noninvasive methods to assess disease activity.
• Intestinal ultrasound (IUS) shows promise, utilizing parameters like bowel wall thickness and Doppler signals.
• The diagnostic value of superb microvascular imaging (SMI) in IUS for IBD is yet to be clarified.

Purpose of the Study:

• To evaluate the diagnostic accuracy of SMI in assessing disease activity in ulcerative colitis (UC) using IUS.
• To compare the performance of SMI with traditional Doppler imaging and established disease activity scores.
• To determine if SMI improves the prediction of endoscopic remission in UC patients.

Main Methods:

• A prospective, single-center, cross-sectional study included 62 UC patients.
• IUS of the sigmoid colon was performed, assessing SMI signals and the International Bowel Ultrasound (IBUS) group Segmental Activity Score (SAS).
• IUS findings were correlated with endoscopic, clinical, and biochemical markers of disease activity.

Main Results:

• Semiquantitative SMI scoring demonstrated substantial interobserver agreement.
• SMI strongly correlated with endoscopic, clinical, and biochemical measures of disease activity.
• SMI did not enhance the overall diagnostic performance of IBUS-SAS for endoscopic disease activity but was superior to Doppler imaging in predicting endoscopic remission.

Conclusions:

• IUS is a precise noninvasive tool for monitoring UC disease activity, particularly for predicting endoscopic remission.
• SMI assessment in the bowel wall appears to be a promising and potentially simpler method for IUS diagnostics in IBD.
• Further research is warranted to fully explore the utility of SMI in IBD management.